It’s a sure sign that when politicians put politics out of the way, things can happen that are in the best interest of the country. In true bipartisanship, both the House of Representatives and the Senate have now approved the “Food and Drug Administration Safety and Innovation Act.” The bill goes to President Obama for signature.
The five-year deal generates billions in user fees for the FDA. The fees will speed innovation, while also providing valuable funding for inspections of foreign facilities – many of which have been central to drug counterfeiting, some resulting in patient deaths.
President Obama has indicated he will sign the law.